NUCORE Trademark

Trademark Overview

On Thursday, July 6, 2017, a trademark application was filed for NUCORE with the United States Patent and Trademark Office. The USPTO has given the NUCORE trademark a serial number of 87517903. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 2, 2021. This trademark is owned by Spine Wave, Inc.. The NUCORE trademark is filed in the Medical Instrument Products category with the following description:

Injectable biomedical compositions, namely, curable polymers, for use in spinal disc nucleus augmentation, replacement or repair, and for use in cartilage repair
nucore

General Information

Serial Number87517903
Word MarkNUCORE
Filing DateThursday, July 6, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 2, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 1, 2018

Trademark Statements

Goods and ServicesInjectable biomedical compositions, namely, curable polymers, for use in spinal disc nucleus augmentation, replacement or repair, and for use in cartilage repair

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, July 13, 2017
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSpine Wave, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressShelton, CT 06484
Party NameSpine Wave, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressShelton, CT 06484

Trademark Events

Event DateEvent Description
Monday, August 2, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 2, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 8, 2020EXTENSION 5 GRANTED
Tuesday, November 24, 2020EXTENSION 5 FILED
Tuesday, December 8, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 24, 2020TEAS EXTENSION RECEIVED
Thursday, June 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 9, 2020EXTENSION 4 GRANTED
Tuesday, June 9, 2020EXTENSION 4 FILED
Tuesday, June 9, 2020TEAS EXTENSION RECEIVED
Thursday, December 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 3, 2019EXTENSION 3 GRANTED
Tuesday, December 3, 2019EXTENSION 3 FILED
Tuesday, December 3, 2019TEAS EXTENSION RECEIVED
Wednesday, June 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 10, 2019EXTENSION 2 GRANTED
Monday, June 10, 2019EXTENSION 2 FILED
Monday, June 10, 2019TEAS EXTENSION RECEIVED
Wednesday, December 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 10, 2018EXTENSION 1 GRANTED
Monday, December 10, 2018EXTENSION 1 FILED
Monday, December 10, 2018TEAS EXTENSION RECEIVED
Tuesday, June 26, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 1, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 1, 2018PUBLISHED FOR OPPOSITION
Wednesday, April 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 23, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 23, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 23, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 23, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 2, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 2, 2017NON-FINAL ACTION E-MAILED
Monday, October 2, 2017NON-FINAL ACTION WRITTEN
Monday, October 2, 2017ASSIGNED TO EXAMINER
Thursday, July 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 10, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

nucore repair nucleus augmentation replacement disc cartilage spinal compositions biomedical namely